Workshop 2021 Vendors
To participate as a vendor at the DPAI 5.0 Workshop please download and complete the application. Contact Nova Marie Smith with any questions.
DPAI 5.0 Vendors
Ibex is the pioneer in applying computational pathology to cancer diagnostics. Based out of Tel Aviv, Israel, the company's machine learning experts, data scientists and pathologists use artificial intelligence (AI) to develop clinical grade algorithms that can detect prostate cancer as accurately as a human pathologist.
Pathologists are challenged to provide accurate and timely analysis as the number of tests increases year-over-year. In an effort to improve their workflow, pathology labs are starting to adopt digital technologies, including AI-based analysis of biopsies. Ibex's algorithms analyzes biopsy images, detects cancerous cells, grades them and can also detect other clinically significant features. The analysis is presented to pathologists either before or after reviewing the case, helping them in reducing error rates and improving operational efficiency by reducing the average time spent on a case.
Deployed in Israel, Europe and the United States, Ibex's solution is the first-ever AI-based cancer diagnosis solution in routine clinical use in a pathology lab and has already demonstrated success in detecting missed cancer cases. The first application Ibex released is for prostate and breast and it works on expanding to additional tissues. Ibex recently raised $15 million from prominent VC funds and corporate investors.
Paige was founded in 2017 by Thomas Fuchs, Dr.Sc., David Klimstra, M.D. and colleagues from Memorial Sloan Kettering Cancer Center (MSK). The company builds computational pathology products designed so patients and their care teams can make effective, more informed treatment decisions. With this new class of AI-based technologies positioned to drive the future of diagnostics, Paige created a platform to deliver this novel technology to pathologists to transform their workflow and increase diagnostic confidence and productivity. Paige‘s products deliver insights to pathologists and oncologists so they can arrive efficiently at more precise diagnoses for patients. Paige is the first company to receive FDA approval for an AI-based digital pathology product.
Sunquest Information Systems Inc. provides diagnostic informatics solutions to laboratories worldwide. With our wide-ranging technical and cross-discipline expertise, and equally deep business acumen, no one is better equipped than Sunquest to transform your lab to meet today’s complex healthcare challenges and deliver next-level performance. Since 1979, Sunquest has helped laboratories and healthcare organizations enhance efficiency, improve patient care, and optimize financial results. Our capabilities include multi-site, multi-disciplinary support for complex anatomic, molecular and genetic testing, and support engagement with physicians and patients outside the hospitals at the point-of-care. Sunquest also provides solutions for public health organizations, in the form of disease surveillance and outbreak management, to promote public health wellness worldwide. Headquartered in Tucson, AZ with additional offices in Calabasas, CA, and India, Sunquest is a global leader in healthcare information technology.
Sunquest Information Systems has gained numerous industry acknowledgements, including several recognitions from Frost & Sullivan, #1 ranking by BlackBook Research, 50 Most Promising Healthcare Solution Providers – 2020 by CIO Review, and Breakthrough Technology by The Boston Globe.
Sunquest is owned by Roper Technologies, a diversified technology company, traded on the New York Stock Exchange under the symbol ROP.